Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction.
Patients who develop acute myocardial infarction due to occlusion in a saphenous vein graft (SVG) constitute a revascularization challenge. Excimer laser angioplasty may have a potential advantage in the treatment of SVGs, since its 308 nanometer wavelength is avidly absorbed by both atherosclerotic plaque and thrombus. The data presented herein support the notion that excimer laser angioplasty is a technology that has a potential role in achieving adequate revascularization outcomes in this selected, high-risk patient population.
Ebersole
Douglas
D
Watson Clinic, LLP, 1600 Lakeland Hills Blvd., Lakeland, FL, 33805 USA. debersole@pol.net
Dahm
Johannes B
JB
Das
Tony
T
Madyoon
Hooman
H
Vora
Kishor
K
Baker
John
J
Hilton
Daid
D
Alderman
Edwin
E
Topaz
On
O
D000368:Aged; D000369:Aged, 80 and over; D017222:Angioplasty, Balloon, Laser-Assisted; D015331:Cohort Studies; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D009204:Myocardial Revascularization; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012501:Saphenous Vein / Q000503:physiopathology / Q000601:surgery*; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome